Visit-based workflow |
|
|
|
|
|
|
|
|
|
Identifying patients due for CRC screening |
|
|
|
|
|
|
|
|
|
Protocol in place for reviewing charts before schedule clinic visits |
X |
X |
X |
X |
X |
X |
X |
X |
X |
Meticulous review of charts before scheduled clinic visits |
X |
X |
X |
X |
|
X |
|
|
X |
Medical assistants have ability to order FIT/FOBT |
|
X |
X |
X |
X |
X |
|
|
|
Distributing FIT/FOBT |
|
|
|
|
|
|
|
|
|
Medical assistants discuss FIT/FOBT screening with patients |
X |
X |
X |
X |
|
|
|
|
|
Medical assistants provide short tutorial and/or pre-label FIT/FOBT kits |
|
X |
X |
X |
|
|
|
|
X |
Medical assistants review FIT/FOBT instructions with patients |
X |
X |
X |
X |
X |
|
|
|
|
Reminders |
|
|
|
|
|
|
|
|
|
Standard, consistent reminders (letters and/or phone calls) |
|
X |
X |
X |
X |
|
X |
X |
X |
Documenting results and conducting follow-up |
|
|
|
|
|
|
|
|
|
Results from FIT/FOBT electronically uploaded into patient chart |
X |
X |
X |
|
|
X |
X |
X |
|
Medical assistants communicate normal results to patients |
X |
X |
X |
X |
X |
X |
X |
X |
X |
Medical assistants communicate abnormal results to patients |
|
X |
|
|
X |
|
X |
|
X |
Nurses communicate abnormal results to patients |
X |
X |
X |
X |
X |
|
|
X |
X |
Population outreach workflow |
|
|
|
|
|
|
|
|
|
Identifying patients due for CRC screening |
|
|
|
|
|
|
|
|
|
Staff generate lists of patients due for screening |
|
X |
X |
X |
X |
X |
|
|
X |
Distributing FIT/FOBT |
|
|
|
|
|
|
|
|
|
Support staff prepare and mail FIT/FOBT kits regularly |
|
X |
X |
X |
X |
X |
|
|
X |
Reminders |
|
|
|
|
|
|
|
|
|
Standard, consistent reminders (letters and/or phone calls) |
|
X |
X |
X |
X |
|
|
|
X |
Documenting results and conducting follow-up |
|
|
|
|
|
|
|
|
|
External labs process FIT/FOBT kits and import results into patient charts |
|
X |
X |
|
|
X |
|
|
X |
Medical assistants communicate normal results to patients |
|
X |
|
|
X |
|
|
|
X |
Medical assistants communicate abnormal results to patients |
|
X |
|
|
X |
|
|
|
X |
Nurses communicate abnormal results to patients |
|
X |
|
|
X |
|
|
|
X |